N-Glycolylneuraminic acid in human tumours***Dedicated to Prof. Dr. Yoshitaka Nagai on the occasion of his 70th birthday.

This publication has 79 references indexed in Scilit:

• A Mouse IgG₁Monoclonal Antibody Specific forN-Glycolyl GM3 Ganglioside Recognized Breast and Melanoma Tumors
  Hybridoma, 2000
• CMP-N-Acetylneuraminic Acid Hydroxylase Is Exclusively Inactive in Humans
  Biochemical and Biophysical Research Communications, 1998
• N‐glycolylneuraminic acid–containing GM1 is a new molecule for serum antibody in Guillain‐Barré syndrome
  Annals of Neurology, 1998
• CMP‐N‐acetylneuraminic acid hydroxylase: the first cytosolic Rieske iron‐sulphur protein to be described in Eukarya
  FEBS Letters, 1996
• Generation of a Murine Monoclonal Antibody Specific for N-Glycolylneuraminic Acid-Containing Gangliosides That Also Recognizes Sulfated Glycolipids
  Hybridoma, 1995
• Diversity in the sialic acids
  Glycobiology, 1992
• The abnormal occurrence and the differentiation-dependent distribution of N-acetyl and N-glycolyl species of the ganglioside GM2 in human germ cell tumors a study with specific monoclonal antibodies
  Cancer, 1990
• Detection of glycoproteins as tumor-associated Hanganutziu-Deicher antigen in human gastric cancer cell line, NUGC4
  Biochemical and Biophysical Research Communications, 1989
• Interaction of bovine erythrocyte N-glycolylneuraminic acid-containing gangliosides and glycoproteins with a human hanganutziu-deicher serum
  Molecular Immunology, 1986
• Antigen of “serum sickness” type of heterophile antibodies in human sera: Identification as gangliosides with N-glycolylneuraminic acid
  Biochemical and Biophysical Research Communications, 1977